Treatment of severe asthma: Expert opinion; [Aǧi{dotless}r asti{dotless}m tedavisi: Uzman görüşü]

Simple item page
dc.contributor.authorTürktaş H.
dc.contributor.authorBavbek S.
dc.contributor.authorÇelik G.
dc.contributor.authorDemir T.
dc.contributor.authorGemicioǧlu B.
dc.contributor.authorGünen H.
dc.contributor.authorKiyan E.
dc.contributor.authorMungan D.
dc.contributor.authorOǧuzülgen I.K.
dc.contributor.authorPolatli M.
dc.contributor.authorSaryal S.
dc.contributor.authorSayiner A.
dc.contributor.authorŞen E.
dc.contributor.authorYildirim N.
dc.contributor.authorYildiz F.
dc.contributor.authorYorgancioǧlu A.
dc.date.accessioned2024-07-22T08:17:13Z
dc.date.available2024-07-22T08:17:13Z
dc.date.issued2014
dc.description.abstractSevere asthmatics account 10% of the all asthmatic population. Those asthmatics whose disease is inadequately controlled account for up to half of the cost for asthma, because they have more emergency room visits, more hospital admission and greater absenteeism from work. New therapeutic options were tried in those patients whose asthma was uncontrolled with standart high dose inhaled corticosteroid and long acting beta-2 agonsit combination therapy. In this paper taking into account the conditions of our country, current literature was reviewed and treatment options was discussed and graded recommendations are made for daily clinical practice in patients with severe treatment-refractory asthma.
dc.identifier.DOI-ID10.5578/tt.7154
dc.identifier.issn04941373
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16980
dc.language.isoEnglish
dc.publisherAnkara University
dc.subjectAdrenal Cortex Hormones
dc.subjectAdrenergic beta-2 Receptor Agonists
dc.subjectAnti-Asthmatic Agents
dc.subjectAsthma
dc.subjectDrug Therapy, Combination
dc.subjectEmergency Service, Hospital
dc.subjectExpert Testimony
dc.subjectHospitalization
dc.subjectHumans
dc.subjectSeverity of Illness Index
dc.subjectantiasthmatic agent
dc.subjectbeta 2 adrenergic receptor stimulating agent
dc.subjectcorticosteroid
dc.subjectarticle
dc.subjectphysician attitude
dc.subjectsevere persistent asthma
dc.subjectasthma
dc.subjectdrug combination
dc.subjectemergency health service
dc.subjectexpert witness
dc.subjecthospitalization
dc.subjecthuman
dc.subjectpathophysiology
dc.subjectseverity of illness index
dc.titleTreatment of severe asthma: Expert opinion; [Aǧi{dotless}r asti{dotless}m tedavisi: Uzman görüşü]
dc.typeArticle

Files

Collections

Scopus Koleksiyonu